Rocket Watch 01 - 03Dec24Watch out for this stock next couple of days. Potential to explode.
Note: This is not a recommendation or investment advice, just a stock to watch. Do your own research.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−26.30 M USD
895.48 K USD
1.86 M
About Mainz Biomed N.V.
Sector
Industry
CEO
Guido Baechler
Website
Headquarters
Mainz
Founded
2021
ISIN
NL0015000LC2
FIGI
BBG012XZKGW7
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MYNZ is 6.68 USD — it has increased by 40.04% in the past 24 hours. Watch Mainz Biomed N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mainz Biomed N.V. stocks are traded under the ticker MYNZ.
MYNZ stock has risen by 33.60% compared to the previous week, the month change is a −22.51% fall, over the last year Mainz Biomed N.V. has showed a −85.73% decrease.
MYNZ reached its all-time high on Jan 18, 2022 with the price of 1,200.00 USD, and its all-time low was 4.30 USD and was reached on Dec 12, 2024. View more price dynamics on MYNZ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MYNZ stock is 47.27% volatile and has beta coefficient of 0.23. Track Mainz Biomed N.V. stock price on the chart and check out the list of the most volatile stocks — is Mainz Biomed N.V. there?
Today Mainz Biomed N.V. has the market capitalization of 13.38 M, it has decreased by −16.17% over the last week.
Yes, you can track Mainz Biomed N.V. financials in yearly and quarterly reports right on TradingView.
Mainz Biomed N.V. is going to release the next earnings report on Apr 15, 2025. Keep track of upcoming events with our Earnings Calendar.
MYNZ earnings for the last quarter are −4.40 USD per share, whereas the estimation was −5.20 USD resulting in a 15.38% surprise. The estimated earnings for the next quarter are −3.60 USD per share. See more details about Mainz Biomed N.V. earnings.
Mainz Biomed N.V. revenue for the last quarter amounts to 300.00 K USD, despite the estimated figure of 600.00 K USD. In the next quarter, revenue is expected to reach 300.00 K USD.
No, MYNZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 71.00 employees. See our rating of the largest employees — is Mainz Biomed N.V. on this list?
Like other stocks, MYNZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mainz Biomed N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mainz Biomed N.V. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mainz Biomed N.V. stock shows the sell signal. See more of Mainz Biomed N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.